Applied Therapeutics, Inc. (APLT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

Applied Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/19/2026 21.75 M $2.18 M   1.61% 14.94%
VANGUARD GROUP INC 01/29/2026 6.35 M $635.30 K   24.50% 4.36%
KNOLL CAPITAL MANAGEMENT, LLC 02/17/2026 6.05 M $605.00 K   -22.43% 4.16%
DELTEC ASSET MANAGEMENT LLC 01/29/2026 3.85 M $384.75 K   100.00% 2.64%
BLACKROCK, INC. 02/12/2026 3.25 M $325.15 K   -15.41% 2.23%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 2.71 M $270.62 K   100.00% 1.86%
PATHSTONE HOLDINGS, LLC 02/13/2026 2.64 M $305.07 K   0.00% 1.82%
JANE STREET GROUP, LLC 02/12/2026 2.09 M $208.74 K   100.00% 1.43%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.49 M $149.33 K   16.80% 1.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/17/2026 1.21 M $121.16 K   -45.22% 0.83%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.05 M $105.19 K   -44.85% 0.72%
UBS GROUP AG 01/29/2026 718.92 K $71.89 K   -62.27% 0.49%
DEUTSCHE BANK AG\ 02/11/2026 622.23 K $62.22 K   0.00% 0.43%
GRAHAM CAPITAL MANAGEMENT, L.P. 02/17/2026 572.76 K $57.28 K   100.00% 0.39%
STATE STREET CORP 02/13/2026 558.18 K $55.82 K   7.65% 0.38%
VIRTU FINANCIAL LLC 02/23/2026 496.29 K $50.00 K   872.79% 0.34%
LYNX1 CAPITAL MANAGEMENT LP 02/17/2026 410.50 K $41.05 K   100.00% 0.28%
MARSHALL WACE, LLP 02/13/2026 337.39 K $33.74 K   -86.73% 0.23%
HENNION & WALSH ASSET MANAGEMENT, INC. 01/14/2026 327.14 K $32.71 K   15.66% 0.22%
EQUITEC PROPRIETARY MARKETS, LLC 02/17/2026 300.60 K $30.06 K   100.00% 0.21%
BANK OF NEW YORK MELLON CORP 02/10/2026 253.58 K $25.36 K   219.29% 0.17%
EQUITEC PROPRIETARY MARKETS, LLC 02/17/2026 252.40 K $25.24 K   100.00% 0.17%
NORTHERN TRUST CORP 02/17/2026 245.14 K $24.51 K   41.12% 0.17%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 03/17/2026 241.90 K $24.19 K   -38.28% 0.17%
GTS SECURITIES LLC 02/13/2026 200.01 K $20.00 K   100.00% 0.14%
MORGAN STANLEY 02/13/2026 178.47 K $17.85 K   -74.98% 0.12%
CREATIVEONE WEALTH, LLC 02/13/2026 169.97 K $17.00 K   69.95% 0.12%
CITIGROUP INC 02/13/2026 163.45 K $16.35 K   2,289.26% 0.11%
GOLDMAN SACHS GROUP INC 03/25/2026 146.22 K $14.62 K   -5.75% 0.10%
CITADEL ADVISORS LLC 02/17/2026 135.00 K $13.50 K   -19.88% 0.09%
ROBLE, BELKO & COMPANY, INC 01/12/2026 65.57 K $7.00 K   112.61% 0.05%
CITADEL ADVISORS LLC 02/17/2026 57.70 K $5.77 K   -30.98% 0.04%
TUDOR INVESTMENT CORP ET AL 02/17/2026 57.45 K $5.75 K   0.00% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 52.69 K $5.27 K   -88.96% 0.04%
SPHERA FUNDS MANAGEMENT LTD. 02/17/2026 50.00 K $5.00 K   0.00% 0.03%
GROUP ONE TRADING, L.P. 02/12/2026 48.68 K $4.87 K   -35.33% 0.03%
SG AMERICAS SECURITIES, LLC 01/09/2026 41.75 K $4.00 K   154.50% 0.03%
ADAMS WEALTH MANAGEMENT 02/18/2026 38.64 K $3.86 K   0.00% 0.03%
CACHETECH INC. 02/18/2026 38.64 K $3.86 K   0.00% 0.03%
DIADEMA PARTNERS LP 02/17/2026 20.20 K $2.02 K   6.32% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 02/17/2026 19.68 K $1.97 K   -42.73% 0.01%
CRESSET ASSET MANAGEMENT, LLC 02/17/2026 17.09 K $1.71 K   0.00% 0.01%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 17.02 K $1.70 K   100.00% 0.01%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 13.41 K $1.34 K   -87.77% 0.01%
JPMORGAN CHASE & CO 02/11/2026 12.06 K $1.21 K   58.09% 0.01%
PERENNIAL INVESTMENT ADVISORS, LLC 02/17/2026 11.60 K $1.16 K   0.00% 0.01%
QUEST PARTNERS LLC 02/09/2026 4.66 K $466   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 02/17/2026 3.11 K $311   -73.36% 0.00%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 2.97 K $297   -14.42% 0.00%
SBI SECURITIES CO., LTD. 02/03/2026 788 $79   -4.25% 0.00%

Applied Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 83 institutional investors and hedge funds held shares of Applied Therapeutics Inc. The most heavily invested institutionals were:

SG Americas Securities, LLC: 0

DELTEC ASSET MANAGEMENT LLC: 0

DEUTSCHE BANK AG\: 0

SBI Securities Co., Ltd.: 0

RHUMBLINE ADVISERS: 0

UBS Group AG: 0

40.45% of Applied Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 55.25 M shares in the last 24 months. This purchase volume represents approximately $5.52 M in transactions.